JP5932778B2 - 乳癌と良性乳房疾患を識別するための方法及びキット - Google Patents

乳癌と良性乳房疾患を識別するための方法及びキット Download PDF

Info

Publication number
JP5932778B2
JP5932778B2 JP2013511503A JP2013511503A JP5932778B2 JP 5932778 B2 JP5932778 B2 JP 5932778B2 JP 2013511503 A JP2013511503 A JP 2013511503A JP 2013511503 A JP2013511503 A JP 2013511503A JP 5932778 B2 JP5932778 B2 JP 5932778B2
Authority
JP
Japan
Prior art keywords
specific
patient
seq
target gene
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2013511503A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013526869A5 (https=
JP2013526869A (ja
Inventor
シュン イェー，
シュン イェー，
フェイ ウー，
フェイ ウー，
チンホワ シュイ，
チンホワ シュイ，
シア モン，
シア モン，
ブリュノ ムジャン，
ブリュノ ムジャン，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux SA
Original Assignee
Biomerieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerieux SA filed Critical Biomerieux SA
Publication of JP2013526869A publication Critical patent/JP2013526869A/ja
Publication of JP2013526869A5 publication Critical patent/JP2013526869A5/ja
Application granted granted Critical
Publication of JP5932778B2 publication Critical patent/JP5932778B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2013511503A 2010-05-28 2010-05-28 乳癌と良性乳房疾患を識別するための方法及びキット Expired - Fee Related JP5932778B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2010/073342 WO2011147096A1 (en) 2010-05-28 2010-05-28 Method and kit for discriminating between breast cancer and benign breast disease

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016088901A Division JP6356175B2 (ja) 2016-04-27 2016-04-27 乳癌と良性乳房疾患を識別するための方法及びキット

Publications (3)

Publication Number Publication Date
JP2013526869A JP2013526869A (ja) 2013-06-27
JP2013526869A5 JP2013526869A5 (https=) 2015-04-23
JP5932778B2 true JP5932778B2 (ja) 2016-06-15

Family

ID=45003218

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013511503A Expired - Fee Related JP5932778B2 (ja) 2010-05-28 2010-05-28 乳癌と良性乳房疾患を識別するための方法及びキット

Country Status (5)

Country Link
US (2) US9410188B2 (https=)
EP (1) EP2576816B1 (https=)
JP (1) JP5932778B2 (https=)
CN (1) CN102918164B (https=)
WO (1) WO2011147096A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10134148B2 (en) * 2013-05-30 2018-11-20 H. Lee Moffitt Cancer Center And Research Institute, Inc. Method of assessing breast density for breast cancer risk applications
US10280461B2 (en) * 2013-10-15 2019-05-07 Conexio Genomics Pty Ltd Major histocompatability complex single nucleotide polymorphisms
CN107765011A (zh) * 2016-08-16 2018-03-06 华明康生物科技（深圳）有限公司 早期癌症筛查方法及试剂盒
CN114214430B (zh) * 2021-12-20 2024-11-12 安徽中盛溯源生物科技有限公司 Nkg2a在检测小鼠人源肿瘤模型中人nk细胞中的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6448086B1 (en) * 2000-01-18 2002-09-10 Diagnostic Systems Laboratories, Inc. Insulin-like growth factor system and cancer
AU2002253878A1 (en) * 2001-01-25 2002-08-06 Gene Logic, Inc. Gene expression profiles in breast tissue
US7171311B2 (en) * 2001-06-18 2007-01-30 Rosetta Inpharmatics Llc Methods of assigning treatment to breast cancer patients
US20070224201A1 (en) 2002-10-02 2007-09-27 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
EP2302073A1 (en) * 2004-07-18 2011-03-30 Epigenomics AG Epigenetic methods and nucleic acids for the detection of breast cell proliferative disorders
US7842467B1 (en) * 2005-05-12 2010-11-30 Celera Corporation Breast disease targets and uses thereof
FR2888252A1 (fr) * 2005-07-07 2007-01-12 Biomerieux Sa Procede pour le diagnostic du cancer du sein
US20090215642A1 (en) * 2005-12-09 2009-08-27 Knudson Alfred G Methods and Compositions for Assessing Alterations in Gene Expression Patterns in Clinically Normal Tissues Obtained from Heterozygous Carriers of Mutant Genes Associated with Cancer and Methods of Use Thereof
EP3796002B1 (en) * 2006-07-14 2023-11-22 The Regents of The University of California Cancer biomarkers and methods of use thereof
CA2700125A1 (en) 2007-09-18 2009-03-26 Board Of Regents Of The University Of Texas System Detection of saliva proteins modulated secondary to ductal carcinoma in situ of the breast
ES2538362T3 (es) * 2007-10-16 2015-06-19 Ventana Medical Systems, Inc. Clasificación, estadificación y pronóstico del cáncer mediante el uso de osteopontina-C
JP5481383B2 (ja) * 2007-11-09 2014-04-23 ミトミクス インコーポレイテッド 癌の検出に使用するための、約１２３１７残基〜約１６２５４残基の間のミトコンドリアｄｎａの欠失
WO2009083780A1 (en) * 2007-12-28 2009-07-09 Ipsogen Breast cancer expresion profiling
JP2009168514A (ja) * 2008-01-11 2009-07-30 Shimadzu Corp 乳癌マーカー及び乳癌の罹患の識別方法
CN101354393A (zh) 2008-02-28 2009-01-28 福建省肿瘤医院 乳腺良恶性肿瘤血清特异蛋白及其应用
WO2011109637A1 (en) * 2010-03-03 2011-09-09 Koo Foundation Sun Yat-Sen Cancer Center Methods for classifying and treating breast cancers

Also Published As

Publication number Publication date
US20130072399A1 (en) 2013-03-21
EP2576816A1 (en) 2013-04-10
EP2576816A4 (en) 2013-12-04
CN102918164A (zh) 2013-02-06
US20160304944A1 (en) 2016-10-20
CN102918164B (zh) 2016-01-27
EP2576816B1 (en) 2017-09-27
WO2011147096A1 (en) 2011-12-01
US9410188B2 (en) 2016-08-09
JP2013526869A (ja) 2013-06-27

Similar Documents

Publication Publication Date Title
JP5916718B2 (ja) 結腸直腸癌の予後判定のための方法及びキット
EP2121988B1 (en) Prostate cancer survival and recurrence
JP2009148269A (ja) 微量胃癌細胞の検出法
JP5932778B2 (ja) 乳癌と良性乳房疾患を識別するための方法及びキット
CN103667437B (zh) 一种大肠癌筛查试剂盒
CN103003444B (zh) 用于结肠直肠癌预后的方法和试剂盒
JP6337358B2 (ja) 個体が大腸癌に罹患する可能性をｉｎ ｖｉｔｒｏで決定するための方法及びキット
CN106148508B (zh) 用于结肠直肠癌预后的方法和试剂盒
US20180051342A1 (en) Prostate cancer survival and recurrence
CN103443295B (zh) 体外确定个体患结直肠癌概率的方法及试剂盒
JP6356175B2 (ja) 乳癌と良性乳房疾患を識別するための方法及びキット
US10072300B2 (en) Kit for the prognosis of colorectal cancer
Gulliksen et al. Microchip for the Diagnosis of Cervical Cancer
HK1192286A (en) Method and kit for determining in vitro the probability for an individual to suffer from colorectal cancer
HK1192286B (en) Method and kit for determining in vitro the probability for an individual to suffer from colorectal cancer

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130418

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140902

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20141127

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20141204

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20141225

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20150130

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20150302

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150908

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20151207

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20160405

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20160428

R150 Certificate of patent or registration of utility model

Ref document number: 5932778

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees